THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis
FRA:TN8 - Deutsche Boerse Ag - US8835561023 - Common Stock - Currency: EUR
TN8 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 17 industry peers in the Life Sciences Tools & Services industry. TN8 has an excellent profitability rating, but there are some minor concerns on its financial health. TN8 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year TN8 was profitable.
In the past year TN8 had a positive cash flow from operations.
In the past 5 years TN8 has always been profitable.
TN8 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
TN8 has a Return On Assets of 6.58%. This is amongst the best in the industry. TN8 outperforms 94.44% of its industry peers.
TN8's Return On Equity of 13.19% is amongst the best of the industry. TN8 outperforms 94.44% of its industry peers.
The Return On Invested Capital of TN8 (6.43%) is better than 61.11% of its industry peers.
TN8 had an Average Return On Invested Capital over the past 3 years of 6.66%. This is in line with the industry average of 6.53%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.58% | ||
| ROE | 13.19% | ||
| ROIC | 6.43% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
1.3 Margins
TN8 has a better Profit Margin (15.19%) than 94.44% of its industry peers.
In the last couple of years the Profit Margin of TN8 has remained more or less at the same level.
TN8's Operating Margin of 18.27% is amongst the best of the industry. TN8 outperforms 88.89% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.34%, TN8 is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
In the last couple of years the Gross Margin of TN8 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.27% | ||
| PM (TTM) | 15.19% | ||
| GM | 41.34% |
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
The number of shares outstanding for TN8 has been reduced compared to 1 year ago.
Compared to 5 years ago, TN8 has less shares outstanding
TN8 has a better debt/assets ratio than last year.
2.2 Solvency
TN8 has an Altman-Z score of 3.44. This indicates that TN8 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.44, TN8 is in line with its industry, outperforming 55.56% of the companies in the same industry.
TN8 has a debt to FCF ratio of 5.08. This is a neutral value as TN8 would need 5.08 years to pay back of all of its debts.
TN8 has a worse Debt to FCF ratio (5.08) than 61.11% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that TN8 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, TN8 is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 5.08 | ||
| Altman-Z | 3.44 |
ROIC/WACC0.64
WACC10.02%
2.3 Liquidity
TN8 has a Current Ratio of 1.77. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8 has a better Current ratio (1.77) than 61.11% of its industry peers.
A Quick Ratio of 1.38 indicates that TN8 should not have too much problems paying its short term obligations.
TN8 has a Quick ratio of 1.38. This is in the better half of the industry: TN8 outperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.30%.
TN8 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.12% yearly.
The Revenue has been growing slightly by 0.96% in the past year.
The Revenue has been growing by 10.92% on average over the past years. This is quite good.
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%
3.2 Future
The Earnings Per Share is expected to grow by 11.41% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.71% on average over the next years.
EPS Next Y7.42%
EPS Next 2Y8.75%
EPS Next 3Y9.92%
EPS Next 5Y11.41%
Revenue Next Year2.11%
Revenue Next 2Y4.09%
Revenue Next 3Y4.98%
Revenue Next 5Y4.71%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.57, TN8 is valued on the expensive side.
Based on the Price/Earnings ratio, TN8 is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Earnings ratio of TN8 to the average of the S&P500 Index (24.21), we can say TN8 is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 15.73, the valuation of TN8 can be described as correct.
Based on the Price/Forward Earnings ratio, TN8 is valued cheaper than 83.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (20.44), we can say TN8 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.57 | ||
| Fwd PE | 15.73 |
4.2 Price Multiples
TN8's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TN8 is cheaper than 61.11% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TN8 is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.82 | ||
| EV/EBITDA | 16.64 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
TN8 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.5
PEG (5Y)1.53
EPS Next 2Y8.75%
EPS Next 3Y9.92%
5. Dividend
5.1 Amount
With a yearly dividend of 0.42%, TN8 is not a good candidate for dividend investing.
The stock price of TN8 dropped by -34.22% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 0.91, TN8 has a dividend in line with its industry peers.
With a Dividend Yield of 0.42, TN8 pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
5.2 History
The dividend of TN8 is nicely growing with an annual growth rate of 15.37%!
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
TN8 pays out 9.16% of its income as dividend. This is a sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.16%
EPS Next 2Y8.75%
EPS Next 3Y9.92%
FRA:TN8 (5/9/2025, 7:00:00 PM)
361.35
-4.15 (-1.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.19%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap136.41B
Analysts81.08
Price Target510.9 (41.39%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.42% |
Yearly Dividend1.35
Dividend Growth(5Y)15.37%
DP9.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.81%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.69%
EPS beat(4)2
Avg EPS beat(4)1.26%
Min EPS beat(4)-0.34%
Max EPS beat(4)3.75%
EPS beat(8)4
Avg EPS beat(8)0.79%
EPS beat(12)7
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)5.33%
Revenue beat(2)2
Avg Revenue beat(2)0.16%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.28%
Revenue beat(8)4
Avg Revenue beat(8)-0.68%
Revenue beat(12)7
Avg Revenue beat(12)1.53%
Revenue beat(16)11
Avg Revenue beat(16)3.62%
PT rev (1m)-17.37%
PT rev (3m)-17.69%
EPS NQ rev (1m)-6.4%
EPS NQ rev (3m)-6.79%
EPS NY rev (1m)-0.37%
EPS NY rev (3m)0.66%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-0.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.57 | ||
| Fwd PE | 15.73 | ||
| P/S | 3.58 | ||
| P/FCF | 22.82 | ||
| P/OCF | 18.86 | ||
| P/B | 3.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.64 |
EPS(TTM)19.46
EY5.39%
EPS(NY)22.98
Fwd EY6.36%
FCF(TTM)15.83
FCFY4.38%
OCF(TTM)19.16
OCFY5.3%
SpS101
BVpS116.28
TBVpS-29.25
PEG (NY)2.5
PEG (5Y)1.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.58% | ||
| ROE | 13.19% | ||
| ROCE | 9.13% | ||
| ROIC | 6.43% | ||
| ROICexc | 6.9% | ||
| ROICexgc | 30.48% | ||
| OM | 18.27% | ||
| PM (TTM) | 15.19% | ||
| GM | 41.34% | ||
| FCFM | 15.68% |
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score8
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 5.08 | ||
| Debt/EBITDA | 2.9 | ||
| Cap/Depr | 47.53% | ||
| Cap/Sales | 3.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.27% | ||
| Profit Quality | 103.22% | ||
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.44 |
F-Score8
WACC10.02%
ROIC/WACC0.64
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)1.3%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%0.78%
EPS Next Y7.42%
EPS Next 2Y8.75%
EPS Next 3Y9.92%
EPS Next 5Y11.41%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%0.18%
Revenue Next Year2.11%
Revenue Next 2Y4.09%
Revenue Next 3Y4.98%
Revenue Next 5Y4.71%
EBIT growth 1Y6.86%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year17.95%
EBIT Next 3Y12.12%
EBIT Next 5Y10.83%
FCF growth 1Y19.66%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y5.98%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%